Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.577
+0.007 (1.30%)
Nov 21, 2024, 11:02 AM EST - Market open
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $22.08 million as of November 21, 2024. Its market cap has decreased by -41.82% in one year.
Market Cap
22.08M
Enterprise Value
-13.81M
1-Year Change
-41.82%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $22.08M, a decrease of -96.80%. That is a compound annual growth rate of -59.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 21.47M | -49.51% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | 690.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 22.90M |
| Inspira Technologies Oxy B.H.N. | 22.85M |
| BioXcel Therapeutics | 22.80M |
| MIRA Pharmaceuticals | 22.53M |
| XTL Biopharmaceuticals | 22.48M |
| Neuronetics | 22.00M |
| Bionano Genomics | 21.87M |
| Enlivex Therapeutics | 21.83M |